Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer

BACKGROUND: The outcome of patients with metastatic colorectal carcinoma (mCRC) following first line therapy is poor, with median survival of less than one year. The purpose of this study was to identify candidate therapeutically targetable somatic events in mCRC patient samples by whole genome sequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugam, Vijayalakshmi, Ramanathan, Ramesh K, Lavender, Nicole A, Sinari, Shripad, Chadha, Manpreet, Liang, Winnie S, Kurdoglu, Ahmet, Izatt, Tyler, Christoforides, Alexis, Benson, Hollie, Phillips, Lori, Baker, Angela, Murray, Christopher, Hostetter, Galen, Von Hoff, Daniel D, Craig, David W, Carpten, John D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074842/
https://www.ncbi.nlm.nih.gov/pubmed/24943349
http://dx.doi.org/10.1186/1755-8794-7-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074842/
https://www.ncbi.nlm.nih.gov/pubmed/24943349
http://dx.doi.org/10.1186/1755-8794-7-36

Ejemplares similares